Table 4.
Table 4.
Male Osteoporosis Risk Estimation Score (MORES)
| Risk Factor | Logistic Regression β Coefficient | MORES Points* |
|---|---|---|
| COPD = chronic obstructive pulmonary disease. | ||
| * Screening threshold is 6 points or greater. | ||
| † Reference category. | ||
| Age | ||
| ≤ 55 years† | 0.00 | 0 |
| 56–74 years | 1.29 | 3 |
| ≤ 75 years | 2.03 | 4 |
| Weight | ||
| ≤ 70 kg (≤ 154 lb) | 3.07 | 6 |
| >70–80 kg (>154–176 lb) | 1.86 | 4 |
| >80 kg (>176 lb)† | 0.00 | 0 |
| COPD | 1.32 | 3 |
Development and Internal Validation of the Male Osteoporosis Risk Estimation Score
Related Articles
Cited By...
- Comparison of the Male Osteoporosis Risk Estimation Score (MORES) With FRAX in Identifying Men at Risk for Osteoporosis
- Validation of the Male Osteoporosis Risk Estimation Score (MORES) in a Primary Care Setting
- Determining Risk of Vertebral Osteoporosis in Men: Validation of the Male Osteoporosis Risk Estimation Score
- Current status of research on osteoporosis in COPD: a systematic review
- ASHP Therapeutic Position Statement on the Prevention and Treatment of Osteoporosis in Adults
- In This Issue: Equity Global Theme Issue on Poverty and Human Development